Compare drug alternatives
Orencia® Alternatives
Orencia®(Abatacept) | Rinvoq®(Upadacitinib) |
|---|---|
Prescription Only | Prescription Only |
| Dosage & Administration | Dosage & Administration comparison data |
Administration | |
Dosing | |
Latin Shorthand | |
| Financial Assistance | Financial Assistance comparison data |
Out-Of-Pocket Costs With Copay Card | |
Annual Cap | |
Assistance Expiration | |
Generics | |
No lower-cost generic available | No lower-cost generic available |
| Physician Advisory | Physician Advisory comparison data |
Adverse Reactions | |
Most common adverse events (≥10%) in RA are headache, upper respiratory tract
infection, nasopharyngitis, and nausea.
Most common adverse reactions (≥10%) in prophylaxis of aGVHD are anemia, hypertension,
CMV reactivation/CMV infection, pyrexia, pneumonia, epistaxis, CD4 lymphocytes
decreased, hypermagnesemia, and acute kidney injury.
. Learn more. | Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and nonradiographic axial spondyloarthritis: Adverse reactions (≥ 1%) were: upper
respiratory tract infections, herpes zoster, herpes simplex, bronchitis,
nausea, cough, pyrexia, acne, and headache.
Atopic Dermatitis: Adverse reactions (≥ 1%) are: upper respiratory tract
infections, acne, herpes simplex, headache, blood creatine phosphokinase
increased, cough, hypersensitivity, folliculitis, nausea, abdominal pain,
pyrexia, increased weight, herpes zoster, influenza, fatigue, neutropenia,
myalgia, and influenza like illness.
Ulcerative colitis: Adverse reactions (≥ 5%) reported during induction or
maintenance are: upper respiratory tract infections, increased blood creatine
phosphokinase, acne, neutropenia, elevated liver enzymes, and rash.. Learn more. |
Mechanism of Actions (MoA) | |
Special Populations | |